-
1 Comment
Andon Health Co., Ltd is currently in a long term downtrend where the price is trading 16.5% below its 200 day moving average.
From a valuation standpoint, the stock is 80.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.9.
Andon Health Co., Ltd's total revenue rose by 198.3% to $567M since the same quarter in the previous year.
Its net income has increased by 452.8% to $105M since the same quarter in the previous year.
Finally, its free cash flow grew by 469.1% to $153M since the same quarter in the previous year.
Based on the above factors, Andon Health Co., Ltd gets an overall score of 4/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE100000Q84 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| PE Ratio | 9.52 |
|---|---|
| Dividend Yield | 0.8% |
| Market Cap | 18B |
| Beta | -0.06 |
| Target Price | 17.81 |
Andon Health Co., Ltd. develops, manufactures, and sells health electronics and intelligent hardware products. It offers sphygmomanometers, blood glucose meter, fetal heart rate meter, COVID-19 test kit, thermometer, atomizer, and neti purifier. Andon Health Co., Ltd. was founded in 1995 and is based in Tianjin, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002432.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
